Innate Pharma S.A.

IPH.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€66,396€70,605€84,225€103,756
Short-Term Investments€14,374€21,851€17,260€16,080
Receivables€4,972€46,489€31,020€13,473
Inventory€0€0€0€0
Other Curr. Assets€0€9,067€7,326€4,947
Total Curr. Assets€85,742€148,012€139,831€138,256
Property Plant & Equip (Net)€5,133€6,322€8,542€10,174
Goodwill€0€0-€40,997€2
Intangibles€0€416€42,553€44,190
Long-Term Investments€19,609€9,796€35,119€39,878
Tax Assets€0€9,006€8,568€5,028
Other NC Assets€575€10,641€14,248€29,969
Total NC Assets€25,317€36,181€68,033€129,241
Other Assets€0€0-€1-€1
Total Assets€111,059€184,193€207,863€267,496
Liabilities
Payables€16,007€8,561€13,656€14,729
Short-Term Debt€8,980€8,936€2,102€30,748
Tax Payable€0€7,021€5,978€7,463
Deferred Revenue€616€5,865€6,560€12,500
Other Curr. Liab.€7,379€9,254€13,042€14,446
Total Curr. Liab.€32,982€39,637€41,338€79,886
LT Debt€22,390€30,957€40,149€13,503
Deferred Rev, NC€2,825€4,618€7,921€25,413
Deferred Tax Liab, NC€0€9,006€8,568€5,028
Other NC Liab.€44,132€39,069€55,736€36,226
Total NC Liab.€69,243€92,655€112,374€80,170
Other Liabilities€0€0€0€0
Cap. Leases€375€835€2,059€2,816
Total Liabilities€102,225€132,292€153,712€160,056
Equity
Pref Stock€0€0€0€0
Common Stock€4,192€4,044€4,011€3,978
Retained Earnings-€386,364-€336,893-€330,316-€272,213
AOCI€27€495€819€456
Other Equity€390,979€384,255€379,637€375,219
Total Equity€8,834€51,901€54,151€107,440
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€111,059€184,193€207,863€267,496
Net Debt-€35,026-€30,712-€41,974-€59,505
Innate Pharma S.A. (IPH.PA) Financial Statements & Key Stats | AlphaPilot